Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 4Classical hematology 1

Conditions

Venous Thromboembolism 8Thrombocythemia, Essential 2Primary Myelofibrosis 2Polycythemia Vera 2Neoplasms 2Thrombosis 1Thrombocytopenia 1Testicular Neoplasms 1Sarcoma 1Ovarian Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Myocardial Infarction 1Myeloproliferative Disorders 1Multiple Myeloma 1Hemorrhage 1Hematoma 1Hematologic Diseases 1Glioblastoma 1Bone Neoplasms 1Acute Coronary Syndrome 1

Interventions

olaparib 5stinging nettle lectin 1peppermint oil 1niraparib 1liposomal doxorubicin 1ferrous fumarate 1apixaban 1angiotensin I (1-7) 1Tretinoin 1Trabectedin 1Surveys and Questionnaires 1Rivaroxaban 1Pharmacokinetics 1Heparin, Low-Molecular-Weight 1Genetic Counseling 1Gemcitabine 1Ferric Oxide, Saccharated 1Epoetin Alfa 1Demography 1Data Collection 1Darbepoetin alfa 1Counseling 1Cognitive Behavioral Therapy 1Carboplatin 1Aspirin 1Anticoagulants 1ALT-836 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ovarian Neoplasms × Aspirin × Classical hematology × Clear all
NCT04352439 2022-09-26

Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy

Duke University

Phase 4 Completed
19 enrolled 10 charts
Classical hematologyGynecologic

Ovarian Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡